Paulus W, Schwarz G, Steinhoff B J
Department of Clinical Neurophysiology, Georg August University, Göttingen, Germany.
Brain. 1996 Apr;119 ( Pt 2):539-49. doi: 10.1093/brain/119.2.539.
We investigated the influence of the antiepileptic drugs carbamazepine (CBZ), phenytoin (PHT) and valproic acid (VPA) on different aspects of visual perception in patients with epilepsy by three different methods. (i) The colour arrangement test Farnsworth Munsell D100. (ii) A monitor system generating 24 different Gaussian dots and 24 different vertical sinusoidal gratings. Luminance increments and decrements for achromatic discrimination and four different colours for chromatic discrimination were investigated with four different sizes each adding up to 24 stimuli. (iii) A Maxwellian view system providing a foveal blue test light either superimposed on a yellow adaptation field (increment threshold) or after switching off this field (postadaptation threshold). Five different adaptation levels were investigated. Patients on PHT offered the most abnormalities, particularly in the D100 and in all Gaussian dots recordings. The individual differences between increment and postadaptation threshold (transient tritanopia effect) were significantly elevated at the four higher adaptation levels, whereas no change was found in the increment thresholds and only for the highest luminance level in the postadaptation thresholds. With VPA, chromatic and achromatic increment discrimination was impaired particularly for larger Gaussian stimuli on the monitor system. Valproic acid also induced a consistent increment threshold increase on the Maxwellian view system, an increase of the postadaptation threshold at the highest luminance level and, like PHT, an increase of the threshold differences at level 3 and 4, but not at the highest background level 5. Patients on CBZ provided normal results in all investigations, with the exception of a slight but significant increase in the D100 error score. Sinusoidal gratings turned out to be much less sensitive than Gaussian dots since they remained unchanged in patients on all three drug groups.
我们通过三种不同方法研究了抗癫痫药物卡马西平(CBZ)、苯妥英(PHT)和丙戊酸(VPA)对癫痫患者视觉感知不同方面的影响。(i)色彩排列测试法恩斯沃思孟塞尔D100。(ii)一个生成24种不同高斯点和24种不同垂直正弦光栅的监测系统。研究了用于无彩色辨别和四种不同颜色用于彩色辨别的亮度增量和减量,每种有四种不同尺寸,共计24种刺激。(iii)一个麦克斯韦观察系统,提供一个中央凹蓝色测试光,要么叠加在黄色适应场(增量阈值)上,要么在关闭该场后(适应后阈值)。研究了五种不同的适应水平。服用PHT的患者出现的异常最多,尤其是在D100测试和所有高斯点记录中。在四个较高的适应水平上,增量阈值和适应后阈值之间的个体差异(瞬态蓝黄型色盲效应)显著升高,而增量阈值没有变化,适应后阈值仅在最高亮度水平有变化。使用VPA时,彩色和无彩色增量辨别受损,尤其是在监测系统上较大的高斯刺激时。丙戊酸还在麦克斯韦观察系统上导致一致的增量阈值增加,在最高亮度水平时适应后阈值增加,并且与PHT一样,在第3和第4水平时阈值差异增加,但在最高背景水平5时没有增加。服用CBZ的患者在所有调查中结果正常,但D100错误分数略有但显著增加。结果表明,正弦光栅的敏感性远低于高斯点,因为在所有三个药物组的患者中其保持不变。